Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Subscribe To Our Newsletter & Stay Updated